Foxp3+ regulatory T cells and related cytokines differentially expressed in plaque vs. guttate psoriasis vulgaris

British Journal of Dermatology

Volumn 163, Issue 1, 2010, Pages 48-56

  Yan, K X ^a   Fang, X ^a   Han, L ^a   Zhang, Z H ^a   Kang, K F ^a   Zheng, Z Z ^a   Huang, Q ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Foxp3; inflammatory cytokines; psoriasis; regulatory T cells; Th17

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SALVAGE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PSORIASIS SEVERITY INDEX; PSORIASIS VULGARIS; REGULATORY T LYMPHOCYTE; SKIN BIOPSY;

ADULT; CASE-CONTROL STUDIES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-17; INTERLEUKIN-6; MALE; MIDDLE AGED; PSORIASIS; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 77954015549     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09742.x     Document Type: Article

References (24)

1. Lowes MA, Kikuchi T, Fuentes-Duculan J et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008 128 : 1207 1211.
2. Sugiyama H, Gyulai R, Toichi E et al. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 2005 174 : 164 173.
3. Wei G, Wei L, Zhu J et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009 30 : 155 167.
4. Yang XO, Nurieva R, Martinez GJ et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008 29 : 44 56.
5. Xu L, Kitani A, Fuss I, Strober W. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol 2007 178 : 6725 6729.
6. Voo KS, Wang YH, Santori FR et al. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci USA 2009 106 : 4793 4798.
7. Beriou G, Costantino CM, Ashley CW et al. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009 113 : 4240 4249.
8. Fletcher JM, Lonergan R, Costelloe L et al. CD39+Foxp3+ regulatory T cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J Immunol 2009 183 : 7602 7610.
9. Verhagen J, Akdis M, Traidl-Hoffmann C et al. Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 2006 117 : 176 183.
10. Bovenschen HJ, van Vlijmen-Willems IM, van de Kerkhof PC, van Erp PE. Identification of lesional CD4+ CD25+ Foxp3+ regulatory T cells in psoriasis. Dermatology 2006 213 : 111 117.
11. Fujimura T, Okuyama R, Ito Y, Aiba S. Profiles of Foxp3+ regulatory T cells in eczematous dermatitis, psoriasis vulgaris and mycosis fungoides. Br J Dermatol 2008 158 : 1256 1263.
12. Chen L, Shen Z, Wang G et al. Dynamic frequency of CD4+ CD25+Foxp3+Treg cells in psoriasis vulgaris. J Dermatol Sci 2008 51 : 200 203.
13. Kollner K, Wimmershoff MB, Hintz C et al. Comparison of the 308-nm excimer laser and a 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the treatment of psoriasis. Br J Dermatol 2005 152 : 750 754.
14. Evers AW, Kleinpenning MM, Smits T et al. Itch and scratching as predictors of time to clearance of psoriasis with narrow-band ultraviolet B therapy. Br J Dermatol 2009 161 : 542 546.
15. Zhou L, Lopes JE, Chong MM et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008 453 : 236 240.
16. Korn T, Reddy J, Gao W et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 2007 13 : 423 431.
17. Miyara M, Amoura Z, Parizot C et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006 203 : 359 370.
18. Zaba LC, Fuentes-Duculan J, Eungdamrong NJ et al. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol 2009 129 : 79 88.
19. Goodman WA, Levine AD, Massari JV et al. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J Immunol 2009 183 : 3170 3176.
20. Tovar-Castillo LE, Cancino-Diaz JC, Garcia-Vazquez F et al. Under-expression of VHL and over-expression of HDAC-1, HIF-1alpha, LL-37, and IAP-2 in affected skin biopsies of patients with psoriasis. Int J Dermatol 2007 46 : 239 246.
21. Godfrey WR, Ge YG, Spoden DJ et al. In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 2004 104 : 453 461.
22. Earle KE, Tang Q, Zhou X et al. In vitro expanded human CD4+ CD25+ regulatory T cells suppress effector T cell proliferation. Clin Immunol 2005 115 : 3 9.
23. Wu J, Yi S, Ouyang L et al. In vitro expanded human CD4+CD25+ regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses. Transplantation 2008 85 : 1841 1848.
24. Gray JD, Liu T, Huynh N, Horwitz DA. Transforming growth factor beta enhances the expression of CD154 (CD40L) and production of tumor necrosis factor alpha by human T lymphocytes. Immunol Lett 2001 78 : 83 8.